Watch Demo

Portugal Cardiovascular Drug Industry Outlook 2022 - 2026

See how Portugal Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Portuguese sales of beta blocking medicine are set to reach $49 million by 2026. This is an increase of 1.2% year-on-year growth, since 2005. Last year, the Portuguese market jumped 5.5%. In 2021, the country ranked 11th in the world. The Czech Republic came first with sales of $47 million. Italy, Canada and Australia came in second, third and fourth, respectively.

Marketing Banner

Portugal Cardiovascular Drug Market Data and Forecasts

How much will Portugal Cardiovascular Drug Market grow to 2026?

Forecast: Antiarrhythmic Medicine Sales in Portugal
Forecast: Cardiovascular System Medicine Sales in Portugal
Forecast: Antihypertensive Medicine Sales in Portugal
Forecast: Calcium Channel Blocking Medicine Sales in Portugal
Forecast: Antiarrhythmic Medicine Sales in Portugal
More in Cardiovascular Drug Industry for 2028